LAP3 promotes glioma progression by regulating proliferation, migration and invasion of glioma cells

International Journal of Biological Macromolecules

Volumn 72, Issue , 2015, Pages 1081-1089

  He, Xiaojuan ^a   Huang, Qingfeng ^a   Qiu, Xiaojun ^a   Liu, Xianchen ^a   Sun, Guan ^a   Guo, Jun ^a   Ding, Zongmei ^a   Yang, Lixiang ^a   Ban, Na ^a   Tao, Tao ^a   Wang, Dongling ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Glioma; LAP3; Overexpression

Indexed keywords

CYTOSOL AMINOPEPTIDASE; LEUCINE AMINOPEPTIDASE 3; MYC PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; BETA CATENIN; CADHERIN; CDK2 PROTEIN, HUMAN; CYCLIN D2; CYCLIN DEPENDENT KINASE 2; LAP3 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CARCINOGENESIS; CELL CYCLE; CELL FUNCTION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; GENETIC TRANSFECTION; GLIOMA; GLIOMA CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; BRAIN TUMOR; CELL MOTION; DISEASE COURSE; ENZYMOLOGY; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR INVASION;

AGED; BETA CATENIN; BRAIN NEOPLASMS; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN D2; CYCLIN-DEPENDENT KINASE 2; DISEASE PROGRESSION; FEMALE; GLIOMA; HUMANS; KAPLAN-MEIER ESTIMATE; LEUCYL AMINOPEPTIDASE; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROPORTIONAL HAZARDS MODELS; SIGNAL TRANSDUCTION;

EID: 84910031850     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2014.10.021     Document Type: Article

References (32)

1. Wen P.Y., Kesari S. The New England Journal of Medicine 2008, 359:492-507.
2. Wei J., Gabrusiewicz K., Heimberger A. Clinical & Developmental Immunology 2013, 2013:285246.
3. Ricard D., Idbaih A., Ducray F., Lahutte M., Hoang-Xuan K., Delattre J.Y. Lancet 2012, 379:1984-1996.
4. Stupp R., Hegi M.E., Mason W.P., van den Bent M.J., Taphoorn M.J., Janzer R.C., Ludwin S.K., Allgeier A., Fisher B., Belanger K., Hau P., Brandes A.A., Gijtenbeek J., Marosi C., Vecht C.J., Mokhtari K., Wesseling P., Villa S., Eisenhauer E., Gorlia T., Weller M., Lacombe D., Cairncross J.G., Mirimanoff R.O. The Lancet Oncology 2009, 10:459-466. R. European Organisation for, T. Treatment of Cancer Brain, G. Radiation Oncology, G. National Cancer Institute of Canada Clinical Trials.
5. Stupp R., Mason W.P., van den Bent M.J., Weller M., Fisher B., Taphoorn M.J., Belanger K., Brandes A.A., Marosi C., Bogdahn U., Curschmann J., Janzer R.C., Ludwin S.K., Gorlia T., Allgeier A., Lacombe D., Cairncross J.G., Eisenhauer E., Mirimanoff R.O. The New England Journal of Medicine 2005, 352:987-996. R. European Organisation for, T. Treatment of Cancer Brain, G. Radiotherapy, G. National Cancer Institute of Canada Clinical Trials.
6. Jansen M., Yip S., Louis D.N. Lancet Neurology 2010, 9:717-726.
7. Rock K., McArdle O., Forde P., Dunne M., Fitzpatrick D., O'Neill B., Faul C. The British Journal of Radiology 2012, 85:e729-e733.
8. Tsujimoto M., Goto Y., Maruyama M., Hattori A. Heart Failure Reviews 2008, 13:285-291.
9. van Loon-Klaassen L.A., Cuypers H.T., van Westreenen H., de Jong W.W., Bloemendal H. Biochemical and Biophysical Research Communications 1980, 95:334-341.
10. Matsui M., Fowler J.H., Walling L.L. Biological Chemistry 2006, 387:1535-1544.
11. Mizutani S., Shibata K., Kikkawa F., Hattori A., Tsujimoto M., Ishii M., Kobayashi H. Expert Opinion on Therapeutic Targets 2007, 11:453-461.
12. Roth M. Clinica Chimica Acta: International Journal of Clinical Chemistry 1964, 9:448-453.
13. Yamazaki T., Akada T., Niizeki O., Suzuki T., Miyashita H., Sato Y. Blood 2004, 104:2345-2352.
14. Pilar Carrera M., Ramirez-Exposito M.J., Duenas B., Dolores Mayas M., Jesus Garcia M., De la Chica S., Cortes P., Ruiz-Sanjuan M., Martinez-Martos J.M. Anticancer Research 2006, 26:1011-1014.
15. Ino K., Kikkawa F., Suzuki T., Kajiyama H., Shibata K., Nomura S., Itakura A., Ito M., Nagasaka T., Hattori A., Tsujimoto M., Mizutani S. Laboratory Investigation: A Journal of Technical Methods and Pathology 2003, 83:1799-1809.
16. Trumbly R.J., Bradley G. Journal of Bacteriology 1983, 156:36-48.
17. O'Farrell P.A., Gonzalez F., Zheng W., Johnston S.A., Joshua-Tor L. Structure 1999, 7:619-627.
18. Shibata K., Kikkawa F., Mizokami Y., Kajiyama H., Ino K., Nomura S., Mizutani S. Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine 2005, 26:9-16.
19. Keller S.R. Biological & Pharmaceutical Bulletin 2004, 27:761-764.
20. Keller S.R., Scott H.M., Mastick C.C., Aebersold R., Lienhard G.E. The Journal of Biological Chemistry 1995, 270:23612-23618.
21. Zhang S., Yang X., Shi H., Li M., Xue Q., Ren H., Yao L., Chen X., Zhang J., Wang H. Journal of Molecular Histology 2014, 45:283-292.
22. Tao T., Cheng C., Ji Y., Xu G., Zhang J., Zhang L., Shen A. Molecular Biology of the Cell 2012, 23:2635-2644.
23. Zhang L., Shen A., Ke Q., Zhao W., Yan M., Cheng C. Journal of Molecular Neuroscience: MN 2012, 47:485-494.
24. Van Meir E.G., Hadjipanayis C.G., Norden A.D., Shu H.K., Wen P.Y., Olson J.J. CA: A Cancer Journal for Clinicians 2010, 60:166-193.
25. Eyler C.E., Wu Q., Yan K., MacSwords J.M., Chandler-Militello D., Misuraca K.L., Lathia J.D., Forrester M.T., Lee J., Stamler J.S., Goldman S.A., Bredel M., McLendon R.E., Sloan A.E., Hjelmeland A.B., Rich J.N. Cell 2011, 146:53-66.
26. Tripathi V., Shen Z., Chakraborty A., Giri S., Freier S.M., Wu X., Zhang Y., Gorospe M., Prasanth S.G., Lal A., Prasanth K.V. PLoS Genetics 2013, 9:e1003368.
27. van den Heuvel S. WormBook: The Online Review of C. elegans Biology 2005, 1-16.
28. Wang Z., Xie Y., Zhang L., Zhang H., An X., Wang T., Meng A. Cell Structure and Function 2008, 33:171-183.
29. Kahlert U.D., Nikkhah G., Maciaczyk J. Cancer Letters 2013, 331:131-138.
30. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Cell 2009, 139:871-890.
31. Suganuma T., Ino K., Shibata K., Kajiyama H., Nagasaka T., Mizutani S., Kikkawa F. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 2005, 11:2686-2694.
32. Singh A., Settleman J. Oncogene 2010, 29:4741-4751.